These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19182492)

  • 1. Thrombospondin in renal disease.
    Hugo C; Daniel C
    Nephron Exp Nephrol; 2009; 111(3):e61-6. PubMed ID: 19182492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-4 mediates TGF-β-induced angiogenesis.
    Muppala S; Xiao R; Krukovets I; Verbovetsky D; Yendamuri R; Habib N; Raman P; Plow E; Stenina-Adognravi O
    Oncogene; 2017 Sep; 36(36):5189-5198. PubMed ID: 28481870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the thrombospondins in healing myocardial infarcts.
    Chatila K; Ren G; Xia Y; Huebener P; Bujak M; Frangogiannis NG
    Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):21-7. PubMed ID: 17266545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin immune regulation and the kidney.
    Ponticelli C; Anders HJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1084-1089. PubMed ID: 28088772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.
    Bige N; Shweke N; Benhassine S; Jouanneau C; Vandermeersch S; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
    Kidney Int; 2012 Jun; 81(12):1226-38. PubMed ID: 22418977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondins, potential drug targets for cardiovascular diseases.
    Mustonen E; Ruskoaho H; Rysä J
    Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):4-12. PubMed ID: 23074998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
    Helkin A; Maier KG; Gahtan V
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thrombospondins.
    Adams JC; Lawler J
    Int J Biochem Cell Biol; 2004 Jun; 36(6):961-8. PubMed ID: 15094109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
    Daniel C; Wagner A; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-based antiangiogenic therapy.
    Zhang X; Lawler J
    Microvasc Res; 2007; 74(2-3):90-9. PubMed ID: 17559888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis.
    Muqri F; Helkin A; Maier KG; Gahtan V
    J Cell Biochem; 2020 Oct; 121(10):4154-4165. PubMed ID: 32348623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.
    Daniel C; Vogelbacher R; Stief A; Grigo C; Hugo C
    PLoS One; 2013; 8(12):e83846. PubMed ID: 24376766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of thrombospondin-1 in the development of kidney diseases].
    Bigé N; Boffa JJ; Lepeytre F; Shweke N
    Med Sci (Paris); 2013 Dec; 29(12):1131-7. PubMed ID: 24356144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.
    Masli S; Sheibani N; Cursiefen C; Zieske J
    Curr Eye Res; 2014 Aug; 39(8):759-74. PubMed ID: 24559320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling.
    Adams JC
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1102-14. PubMed ID: 15094125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
    Lawler PR; Lawler J
    Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
    Simantov R; Febbraio M; Silverstein RL
    Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proangiogenic Properties of Thrombospondin-4.
    Muppala S; Frolova E; Xiao R; Krukovets I; Yoon S; Hoppe G; Vasanji A; Plow E; Stenina-Adognravi O
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1975-86. PubMed ID: 26139464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondins Differentially Regulate Proteins Involved in Arterial Remodeling.
    Kassem MM; Helkin A; Maier KG; Gahtan V
    Physiol Res; 2019 Dec; 68(6):893-900. PubMed ID: 31647293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.